• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAB
Click for more information
0.00% 1.0¢

PATRYS LIMITED

Market Cap $20.57M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Patrys Limited is an Australia-based company, which is focused on the development of its... Patrys Limited is an Australia-based company, which is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers. The Company's deoxymab platform is based on the deoxymab 3E10 antibody that was identified as an autoantibody in a mouse model of the human disease systemic lupus erythematosus. It has developed two humanized forms of deoxymab 3E10, both of which have improved activity over the original deoxymab 3E10 antibody: PAT-DX1, which is a dimer (two joined subunits) of the short chain from the binding domain of deoxymab 3E10, and PAT-DX3, which is a full-sized Immunoglobulin G antibody. Deoxymabs, such as PAT-DX1 and PAT-DX3, can be used to target nanoparticles carrying a payload of anti-cancer drugs specifically to tumors. Its PAT-DX1- nanoparticles (NP) pipeline involves using its PAT-DX1 to develop a new drug based on the targeted delivery of NP carrying therapeutic payloads to the inside of cancer cells.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAB
Ann: Presentation to highlight broader potential of Deoxymabs
2
08:42 79 23K
08:42 Last post  gassed Comments Created with Sketch.  79  Views Created with Sketch.  23K 
PAB
Ann: Positive preclinical data for deoxymabs in vasculitis 		09/04/24 6 2.0K
09/04/24 Last post  salty74 Comments Created with Sketch.  6  Views Created with Sketch.  2.0K 
PAB
M & A Activities 		02/04/24 1 483
02/04/24 Last post  Outgoing123 Comments Created with Sketch.  1  Views Created with Sketch.  483 
PAB
Ann: Change of Director's Interest Notice 		22/03/24 0 343
22/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  343 
PAB
Ann: Notification of cessation of securities - PAB 		22/03/24 0 228
22/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  228 
PAB
Ann: Appendix 4D - Half Year Accounts - 31 December 2023 		01/03/24 10 3.9K
01/03/24 Last post  salty74 Comments Created with Sketch.  10  Views Created with Sketch.  3.9K 
PAB
2024 An Eventful Year
2
29/02/24 61 23K
29/02/24 Last post  Lumpster Comments Created with Sketch.  61  Views Created with Sketch.  23K 
PAB
Ann: Appendix 4C - Quarterly - 31 December 2023 		28/01/24 10 4.0K
28/01/24 Last post  Thejerry01 Comments Created with Sketch.  10  Views Created with Sketch.  4.0K 

See All Discussions arrow Created with Sketch.

Timeline

Positive preclinical data for deoxymabs in vasculitis
09 Apr 09:31
 
Change of Director's Interest Notice
22 Mar 09:53
 
Notification of cessation of securities - PAB
22 Mar 09:48
 
Presentation to highlight broader potential of Deoxymabs
04 Mar 10:06
 
Appendix 4D - Half Year Accounts - 31 December 2023
23 Feb 14:51
 
Appendix 4C - Quarterly - 31 December 2023
23 Jan 09:52
 
View More arrow Created with Sketch.

Featured News

TLX Telix Pharmaceuticals granted US-FDA fast track designation for brain cancer detection
right-arrow Created with Sketch.
WGX Bluebird-South Junction soars 134% higher in resource for Westgold
right-arrow Created with Sketch.
RCE Recce Pharmaceuticals up on new antibiotic production milestone
right-arrow Created with Sketch.
RDN Raiden rolls up heritage work at twin Pilbara lithium plays
right-arrow Created with Sketch.
NEWS Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold
right-arrow Created with Sketch.
BGD Barton share purchase plan strikes a chord for SA gold projects
right-arrow Created with Sketch.

(20min delay)
Last
1.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $20.57M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $15K 1.5M

Buyers (Bids)

No. Vol. Price($)
5 1784025 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 1440629 5
View Market Depth
Last trade - 11.56am 16/04/2024 (20 minute delay) ?
Last
0.9¢ 		  Change
0.000 ( 10.0 %)
Open High Low Volume
0.9¢ 0.9¢ 0.9¢ 150000
Last updated 13.43pm 16/04/2024 ?
PAB (ASX) Chart

Top Stories

Canada's Hillcrest Energy (CSE.HEAT) partners with BC's Powertech Labs

Canada-based Hillcrest Energy Technologies has teamed up with British Columbia-based Powertech Labs to test Hillcrest's ZVS technology.
Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold Depending on what interests you more, there were two big stories this week for the international finance space.
Chariots of fire on pole to meet resurgent US lithium security focus. Chariot Corporation is a company in a hurry.Since listing on the Australian stock exchange (ASX) in October, Chariot’s focus has been on building up a significant suite of lithium projects across three US states with the goal of securing future supply of the mineral to fulfil a vo...
Market Update: Energy keeps light bright in a sea of red The ASX is down .7 of a per cent with every sector - except energy - in the red and real estate diving nearly 2 per cent mid-session.
Recce Pharmaceuticals up 6% on new antibiotic production milestone Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.

Featured News

NEWS Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold
right-arrow Created with Sketch.
WGX Bluebird-South Junction soars 134% higher in resource for Westgold
right-arrow Created with Sketch.
BGD Barton share purchase plan strikes a chord for SA gold projects
right-arrow Created with Sketch.
OZM OzAurum Resources ups the ante on the charge for lithium in Brazi
right-arrow Created with Sketch.
TLX Telix Pharmaceuticals granted US-FDA fast track designation for brain cancer detection
right-arrow Created with Sketch.
RCE Recce Pharmaceuticals up on new antibiotic production milestone
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.